Andrew Mendians, DO
Otolaryngology/Facial Plastic Surgery · Manistee, MINPI 1386692218
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medical Device Business Services, Inc. at 56.8% of the total. Reporting peaked in 2019 at $1,249 and has fallen 77.2% since, to $285 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in MI, where the typical reported total is $2,119.
Across 27 payments — averaging $65.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Acclarent, Inc$299
- Integra Lifesciences Corporation$101
- Aerin Medical Inc.$84
- Stryker$77
- Sanofi$69
- plus $138 from 6 others
What the payments were for
- Travel & lodging$1,00957%
- Food & beverage$75442%
- Education$141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $1,009 |
| Acclarent, Inc | 10 | $299 |
| Integra Lifesciences Corporation | 2 | $101 |
| Aerin Medical Inc. | 3 | $84 |
| Stryker | 2 | $77 |
| Sanofi | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| GSK | 1 | $17 |
| Smith+Nephew | 1 | $14 |
| Medtronic | 1 | $13 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,777 in reported general payments places this provider in the 45th percentile of 31 otolaryngology/facial plastic surgery providers in Michigan.
See all otolaryngology/facial plastic surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $48,453 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $40,457 |
| Epinephrine | 56 | $14,187 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $13,358 |
| Montelukast Sodium | 858 | $12,227 |
| Fluticasone Propionate | 736 | $11,137 |
| Azelastine Hcl | 348 | $8,895 |
| Ipratropium Bromide | 180 | $7,195 |
| Olopatadine Hcl | 33 | $3,642 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $3,540 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $2,122 |
| Famotidine | 173 | $1,750 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,707 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $1,631 |
| Cefdinir | 77 | $1,171 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $17 | $53,81585 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 31 otolaryngology/facial plastic surgery providers in Michigan.
Other otolaryngology/facial plastic surgery in Manistee
- James HengyManistee$2K
- Prasad ThottamWest Bloomfield$43K
- Ahmed SufyanEast Lansing$16K
- Warren BrandesMadison Heights$12K
- Amber BerryKalamazoo$9K
- Miles NeumannSouthfield$6K
- Kenneth GwinnShelby Township$5K
- Jason ChesneyEast Lansing$5K
- Christine LepoudreNovi$5K
- Mark TomaDearborn$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.